We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the ...

Illumina (NASDAQ:ILMN) supports global genomic science as nasdaq futures discussions include advanced life sciences platforms ...

Learn more about whether Charles River Laboratories International, Inc. or Illumina, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...

After reporting preliminary sales figures that were south of industry watchers' forecasts, shares in gene-sequencing giant Illumina Corp. toppled this week. Meanwhile, better-than-anticipated sales at ...

Slowing sales and profit growth and changes at the top derailed this game-changing maker of genetic sequencing machines last year. Illumina has installed over 7,500 of its gene-sequencing machines for ...

Illumina, Inc.'s acquisition of GRAIL, Inc. was disastrous and created all kinds of problems, but the company is refocusing on its profitable core gene sequencing business. ILMN's revenue growth has ...

Industries across the board today are facing the challenge of integrating cutting-edge technologies with established infrastructures. Companies are bringing together different data systems using data ...

Last month, gene-sequencing Goliath Illumina Corp's (ILMN-0.82%) longtime CEO Jay Flatley announced he's handing over the day to day reins at Illumina to technology guru Francis deSouza in July.

(Reuters) - A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc's challenge to a federal agency order requiring the biotechnology company to divest cancer diagnostic test ...

Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the ...

Slowing demand and the transition of longtime CEO Jay Flatley into his new role of executive chairman caused shares in Illumina, Inc. (NASDAQ: ILMN) to slump 33.3% in 2016, according to S&P Global ...